1. Home
  2. AGIO vs UP Comparison

AGIO vs UP Comparison

Compare AGIO & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.92

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

HOLD

Current Price

$0.71

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
UP
Founded
2007
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AGIO
UP
Price
$28.92
$0.71
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$32.13
N/A
AVG Volume (30 Days)
1.5M
3.7M
Earning Date
02-12-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$44,791,000.00
$757,468,000.00
Revenue This Year
$28.75
$174.46
Revenue Next Year
$139.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
36.26
N/A
52 Week Low
$22.24
$0.59
52 Week High
$46.00
$3.50

Technical Indicators

Market Signals
Indicator
AGIO
UP
Relative Strength Index (RSI) 50.24 44.29
Support Level $24.16 $0.61
Resistance Level $27.95 $0.69
Average True Range (ATR) 1.20 0.08
MACD 0.50 0.03
Stochastic Oscillator 82.82 43.32

Price Performance

Historical Comparison
AGIO
UP

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: